Results 71 to 80 of about 722,631 (394)
Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
The leading malaria vaccine in development is the circumsporozoite protein (CSP)-based particle vaccine, RTS,S, which targets the pre-erythrocytic stage of Plasmodium falciparum infection.
K. Collins+4 more
semanticscholar +1 more source
Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity [PDF]
Cyclic GMP-AMP (cGAMP) is an immunostimulatory molecule produced by cGAS that activates STING. cGAMP is an adjuvant when administered alongside antigens. cGAMP is also incorporated into enveloped virus particles during budding.
Beveridge, Ryan+15 more
core +2 more sources
Venom peptides have shown promise in treating pain. Our study uses computer screening to identify a peptide that targets a sodium channel (NaV1.7) linked to chronic pain. We produced the peptide in the laboratory and refined its design, advancing the search for innovative pain therapies.
Gagan Sharma+8 more
wiley +1 more source
High-speed imaging of ESCRT recruitment and dynamics during HIV virus like particle budding.
Endosomal sorting complexes required for transport proteins (ESCRT) catalyze the fission of cellular membranes during budding of membrane away from the cytosol.
Shilpa Gupta+2 more
doaj +1 more source
Investigation of the particle-particle interaction effects in the cosmic Zevatron based on cyclotron auto-resonance by particle-in-cell simulations [PDF]
Cyclotron autoresonance acceleration has been recently advanced as a potential mechanism for accelerating nuclei to ZeV energies (1 ZeV = $10^{21}$ eV). All results have been based on single- and many-particle calculations employing analytic solutions to the relativistic equations of motion in the combined magnetic and radiation fields, excluding ...
arxiv
Virus-like particles as vaccine adjuvants
Virus-like particles (VLPs) consist of one or more viral coat proteins that assemble into particles. They can be taken up by antigen presenting cells (APC), peptides derived from them are presented on MHC class I molecules at the cell surface, and thereby prime a CD8+ T cell response, either against the particle-forming protein itself (such as ...
openaire +4 more sources
FOXL2 c.402C>G mutation drives granulosa cell tumors. Using CRISPR technology, we selectively corrected this mutation, reducing malignancy and increasing sensitivity to dasatinib and ketoconazole. Transcriptomic changes revealed potential therapeutic targets, demonstrating CRISPR's promise for treating this rare ovarian cancer.
Sandra Amarilla‐Quintana+17 more
wiley +1 more source
Effective chikungunya virus-like particle vaccine produced in insect cells. [PDF]
The emerging arthritogenic, mosquito-borne chikungunya virus (CHIKV) causes severe disease in humans and represents a serious public health threat in countries where Aedes spp mosquitoes are present. This study describes for the first time the successful
Stefan W Metz+7 more
doaj +1 more source
Human parvovirus B19 (HPV B19) is pathogenic to human, which can cause fifth disease, transient aplastic crisis, arthritis, myocarditis, autoimmune disorders, hydrops fetalis, and so on.
Shuai Shao+12 more
doaj +1 more source
TOMM20 increases cancer aggressiveness by maintaining a reduced state with increased NADH and NADPH levels, oxidative phosphorylation (OXPHOS), and apoptosis resistance while reducing reactive oxygen species (ROS) levels. Conversely, CRISPR‐Cas9 knockdown of TOMM20 alters these cancer‐aggressive traits.
Ranakul Islam+9 more
wiley +1 more source